Symbol
Entera Bio Ltd.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.60
Current price of the stock
$29K
Trading volume of the stock
$60.2M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
525.00%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
6.61
Current ratio
-
Gross profit margin
-7192.86%
Operating profit margin
-7192.86%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-7192.86%
Pretax profit margin
-7192.86%
Net profit margin
-46.82%
Measures profitability relative to shareholders' equity
-46.82%
ROE excluding intangible assets
-39.03%
Measures profitability relative to total assets
-46.82%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
1.00
Receivables turnover ratio
90.00
Average number of days it takes to collect receivables
-6.15
Measures valuation relative to earnings
-
P/E based on future earnings estimates
608.40
Measures valuation relative to sales
9.05
Measures valuation relative to book value
-3.01
Measures valuation relative to operating cash flow
-3.01
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
